Holista Colltech Limited (ASX:HCT)

Market Cap	36.86M
Revenue (ttm)	5.60M
Net Income (ttm)	-84.21K
Shares Out	335.05M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	741,228
Average Volume	448,552
Open	0.0990
Previous Close	0.0990
Day's Range	0.0950 - 0.1100
52-Week Range	0.0070 - 0.1100
Beta	0.72
RSI	92.44
Earnings Date	Aug 27, 2025

About CTI BioPharma

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it provides GI LiTE, a premix glycemi...

• Industry: Packaged Foods
• Sector: Consumer Staples
• CEO: Leong Loong
• Employees: 58
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: HCT

Financial Performance

In 2024, Holista Colltech's revenue was 5.60 million, a decrease of -5.86% compared to the previous year's 5.95 million. Losses were -84,214, -98.25% less than in 2023.